Baolingbao BiologyLtd Balance Sheet Health
Financial Health criteria checks 6/6
Baolingbao BiologyLtd has a total shareholder equity of CN¥2.0B and total debt of CN¥341.7M, which brings its debt-to-equity ratio to 17.5%. Its total assets and total liabilities are CN¥2.7B and CN¥697.8M respectively. Baolingbao BiologyLtd's EBIT is CN¥58.7M making its interest coverage ratio 3.4. It has cash and short-term investments of CN¥237.8M.
Key information
17.5%
Debt to equity ratio
CN¥341.71m
Debt
Interest coverage ratio | 3.4x |
Cash | CN¥237.76m |
Equity | CN¥1.96b |
Total liabilities | CN¥697.85m |
Total assets | CN¥2.65b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 002286's short term assets (CN¥850.7M) exceed its short term liabilities (CN¥596.6M).
Long Term Liabilities: 002286's short term assets (CN¥850.7M) exceed its long term liabilities (CN¥101.2M).
Debt to Equity History and Analysis
Debt Level: 002286's net debt to equity ratio (5.3%) is considered satisfactory.
Reducing Debt: 002286's debt to equity ratio has reduced from 40.6% to 17.5% over the past 5 years.
Debt Coverage: 002286's debt is well covered by operating cash flow (78.1%).
Interest Coverage: 002286's interest payments on its debt are well covered by EBIT (3.4x coverage).